Latest Announcements

BSE & NSE corporate filings with AI summaries

BSEGeneralM&A4d ago

Dr. Agarwals Health Care Ltd

Outcome of Board Meeting held on October 20, 2026 in connection with a Material Update on Scheme of Amalgamation between Dr. Agarwal''s Eye Hospital Limited and Dr. Agarwal''s Health Care Limited, is enclosed.

Dr. Agarwal's Health Care Ltd has announced the outcome of its Board Meeting held on October 20, 2026, in connection with a Material Update on the Scheme of Amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited. The Board has noted, considered, and approved the effectiveness of the Scheme, alteration of the authorized share capital, and fixation of the record date for allotment of consideration shares to eligible shareholders.

Read more →📎 1 attachment
BSECompany Update▼ NegativeM&A4d ago

Genomic Valley Biotech Ltd

Disclosure under Regulation 30 and Regulation 30A of the SEBI (LODR) Regulations, 2015 regarding Mr. Yogesh Agrawal (hereinafter referred to as the "Promoters" or "Promoter Sellers") of the Company has entered into Share Purchase Agreement ("SPA") with Mr. Pankaj Grover and Mr. Abhisek Gupta (hereinafter referred to as "Acquirers") pursuant to which the promoters sellers propose to sell entire of their shareholding in the company to the acquirers.

Genomic Valley Biotech Ltd's promoter, Yogesh Agrawal, has entered into a Share Purchase Agreement with Pankaj Grover and Abhisek Gupta to sell their entire shareholding in the company. The transaction will result in the acquirers acquiring control over the company and will attract an obligation to make an open offer to public shareholders.

Read more →📎 1 attachment
BSEBoard MeetingM&A5d ago

Soni Medicare Ltd

Soni Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve Healthcare Operations and Management (O&M) Framework Agreement with a suitable vendor for the operations and management of Soni Hospital, a unit of Soni Medicare Limited

Soni Medicare Ltd has informed BSE that a meeting of the Board of Directors is scheduled on 26/10/2026 to consider a Healthcare Operations and Management (O&M) Framework Agreement with a vendor for Soni Hospital.

Read more →📎 1 attachment
BSEAGM/EGMM&A5d ago

Quality Power Electrical Equipments Ltd

Proceedings of the Extra Ordinary General Meeting of the Company held on Monday, 19th October 2026, through Video Conferencing/Other Audio-Visual means.

Quality Power Electrical Equipments Ltd held an Extra Ordinary General Meeting on October 19, 2026, through video conferencing. The meeting was attended by 35 members, and the company's chairman and managing director, Thalavaidurai Pandyan, briefed the shareholders on the proposed acquisition of Winwin Speciality Insulators Limited, a QIP for funding the company's expansion plans, and promoter financing arrangements.

Read more →📎 1 attachment
BSECompany UpdateM&A5d ago

Clio Infotech Ltd

Please find enclosed Announcement as to the approval of investment by way of subscription to share capital in a foreign entity resulting it becoming subsidiary of the company.

Clio Infotech Ltd has approved an investment in Clio Quantinfra Limited, a UK-based company, which will become a subsidiary after the investment. The investment amount is approximately £1000, and the company will subscribe to 1000 equity shares. The trading window for dealing securities has been closed until 48 hours after the declaration of financial results for the quarter and half-year ended September 30, 2026.

Read more →📎 1 attachment
BSECompany UpdateM&A5d ago

Genomic Valley Biotech Ltd

Fintellectual Corporate Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Public Announcement ("PA") under Regulation 3(1) and Regulation 4 read with Regulation 13(1), 14, and 15 (1) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments thereto for the attention of the Public Shareholders of Genomic Valley Biotech Ltd ("Target Company").

Genomic Valley Biotech Ltd has received a public announcement from Fintellectual Corporate Advisors Pvt Ltd regarding an open offer for the acquisition of up to 7,94,170 equity shares, representing 26.00% of the voting share capital, by Mr. Pankaj Grover and Mr. Abhisek Gupta at a price of ₹30 per share.

Read more →📎 1 attachment
BSECompany UpdateM&A5d ago

Hiliks Technologies Ltd

Navigant Corporate Advisors Ltd ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer for the attention of the Equity Shareholders of Hiliks Technologies Ltd ("Target Company").

Hiliks Technologies Ltd has received a draft letter of offer from Navigant Corporate Advisors Ltd for the acquisition of up to 36,92,000 equity shares, representing 26.00% of the company's expanded equity and voting share capital, at a price of Rs. 72/- per share.

Read more →📎 1 attachment
BSEGeneralM&A5d ago

CL Educate Ltd

The Board of Directors of CL Educate Limited ('Company' or 'CL Educate') at its meeting held today, i.e., on October 19, 2026, has, inter alia, considered and approved the Scheme of Amalgamation ('Scheme') between DEXIT Global Limited ('DEXIT' or 'Amalgamating Company') and the Company (hereinafter referred to as 'Amalgamated Company') and their respective shareholders and creditors under Sections 230 to 232 of the Companies Act, 2013 and rules made thereunder.

CL Educate Ltd has approved a Scheme of Amalgamation between DEXIT Global Limited, a wholly owned subsidiary, and the Company, under Sections 230 to 232 of the Companies Act, 2013.

Read more →📎 1 attachment
BSECompany UpdateM&A5d ago

CL Educate Ltd

Disclosure under Regulation 30 of SEBI(LODR), Regulation, 2015, Intimation of Approval of Scheme of Amalgamation of DEXIT Global Limited, a wholly owned subsidiary of the Company, into and with CL Educate Limited

CL Educate Ltd has approved the Scheme of Amalgamation of DEXIT Global Limited, a wholly owned subsidiary, into and with CL Educate Limited, subject to approval from the National Company Law Tribunal and regulatory authorities.

Read more →📎 1 attachment
BSEAGM/EGM▼ NegativeM&A6d ago

Choksi Laboratories Ltd

The voting result along with the scrutinizer report the e-voting and remote e-voting held at EGM of the company held on 17.10.2026.

Choksi Laboratories Ltd held an EGM on 17th October 2026, where resolutions were not approved by the shareholders with requisite majority. The company submitted the voting results and a combined scrutinizer's report on remote e-voting and e-voting facility. The resolutions required special resolution, but the promoter and promoter group were not interested in the agenda/resolution.

Read more →📎 1 attachment
BSECompany UpdateM&A6d ago

Inani Securities Ltd

Bonanza Portfolio Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulation 3(1) and 4 read with 13 (4), 14 (3), and 15(2) of such other applicabel provisions of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 as amended, to the Public Shareholders of Inani Securities Ltd ("Target Company").

Bonanza Portfolio Ltd has submitted a Detailed Public Statement to BSE regarding its open offer for Inani Securities Ltd.

Read more →📎 1 attachment